Literature DB >> 15485863

Many amino acid substitutions in a hypoxia-inducible transcription factor (HIF)-1alpha-like peptide cause only minor changes in its hydroxylation by the HIF prolyl 4-hydroxylases: substitution of 3,4-dehydroproline or azetidine-2-carboxylic acid for the proline leads to a high rate of uncoupled 2-oxoglutarate decarboxylation.

Dongxia Li1, Maija Hirsilä, Peppi Koivunen, Mitchell C Brenner, Leon Xu, Charles Yang, Kari I Kivirikko, Johanna Myllyharju.   

Abstract

Three human prolyl 4-hydroxylases (P4Hs) regulate the hypoxia-inducible transcription factors (HIFs) by hydroxylating a Leu-Xaa-Xaa-Leu-Ala-Pro motif. We report here that the two leucines in the Leu-Glu-Met-Leu-Ala-Pro core motif of a 20-residue peptide corresponding to the sequence around Pro(564) in HIF-1alpha can be replaced by many residues with no or only a modest decrease in its substrate properties or in some cases even a slight increase. The glutamate and methionine could be substituted by almost any residue, eight amino acids in the former position and four in the latter being even better for HIF-P4H-3 than the wild-type residues. Alanine was by far the strictest requirement, because no residue could fully substitute for it in the case of HIF-P4H-1, and only serine or isoleucine, valine, and serine did this in the cases of HIF-P4Hs 2 and 3. Peptides with more than one substitution, having the core sequences Trp-Glu-Met-Val-Ala-Pro, Tyr-Glu-Met-Ile-Ala-Pro, Ile-Glu-Met-Ile-Ala-Pro, Trp-Glu-Met-Val-Ser-Pro, and Trp-Glu-Ala-Val-Ser-Pro were in most cases equally as good or almost as good substrates as the wild-type peptide. The acidic residues present in the 20-residue peptide also played a distinct role, but alanine substitution for any six of them, and in some combinations even three of them, had no negative effects. Substitution of the proline by 3,4-dehydroproline or l-azetidine-2-carboxylic acid, but not any other residue, led to a high rate of uncoupled 2-oxoglutarate decarboxylation with no hydroxylation. The data obtained for the three HIF-P4Hs in various experiments were in most cases similar, but in some cases HIF-P4H-3 showed distinctly different properties.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485863     DOI: 10.1074/jbc.M410287200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Regulation of cellular levels of Sprouty2 protein by prolyl hydroxylase domain and von Hippel-Lindau proteins.

Authors:  Kimberly Anderson; Kyle A Nordquist; Xianlong Gao; Kristin C Hicks; Bo Zhai; Steven P Gygi; Tarun B Patel
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

2.  Inverse solvent isotope effects demonstrate slow aquo release from hypoxia inducible factor-prolyl hydroxylase (PHD2).

Authors:  Shannon C Flagg; Nitai Giri; Serap Pektas; Michael J Maroney; Michael J Knapp
Journal:  Biochemistry       Date:  2012-08-09       Impact factor: 3.162

3.  Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1.

Authors:  Weibo Luo; Hongxia Hu; Ryan Chang; Jun Zhong; Matthew Knabel; Robert O'Meally; Robert N Cole; Akhilesh Pandey; Gregg L Semenza
Journal:  Cell       Date:  2011-05-27       Impact factor: 41.582

4.  Sequence and functional characterization of hypoxia-inducible factors, HIF1α, HIF2αa, and HIF3α, from the estuarine fish, Fundulus heteroclitus.

Authors:  Ian K Townley; Sibel I Karchner; Elena Skripnikova; Thomas E Wiese; Mark E Hahn; Bernard B Rees
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-12-30       Impact factor: 3.619

Review 5.  Prolyl 4-hydroxylase.

Authors:  Kelly L Gorres; Ronald T Raines
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-04       Impact factor: 8.250

Review 6.  Genetic causes of erythrocytosis and the oxygen-sensing pathway.

Authors:  Frank S Lee
Journal:  Blood Rev       Date:  2008-06-05       Impact factor: 8.250

7.  Identification of a region on hypoxia-inducible-factor prolyl 4-hydroxylases that determines their specificity for the oxygen degradation domains.

Authors:  Diego Villar; Alicia Vara-Vega; Manuel O Landázuri; Luis Del Peso
Journal:  Biochem J       Date:  2007-12-01       Impact factor: 3.857

8.  ERK5/BMK1 is a novel target of the tumor suppressor VHL: implication in clear cell renal carcinoma.

Authors:  Laura Arias-González; Inmaculada Moreno-Gimeno; Antonio Rubio del Campo; Leticia Serrano-Oviedo; María Llanos Valero; Azucena Esparís-Ogando; Miguel Ángel de la Cruz-Morcillo; Pedro Melgar-Rojas; Jesús García-Cano; Francisco José Cimas; María José Ruiz Hidalgo; Alfonso Prado; Juan Luis Callejas-Valera; Syong Hyun Nam-Cha; José Miguel Giménez-Bachs; Antonio S Salinas-Sánchez; Atanasio Pandiella; Luis del Peso; Ricardo Sánchez-Prieto
Journal:  Neoplasia       Date:  2013-06       Impact factor: 5.715

9.  Oxygen-regulated beta(2)-adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHL.

Authors:  Liang Xie; Kunhong Xiao; Erin J Whalen; Michael T Forrester; Robert S Freeman; Guohua Fong; Steven P Gygi; Robert J Lefkowitz; Jonathan S Stamler
Journal:  Sci Signal       Date:  2009-07-07       Impact factor: 8.192

Review 10.  Oxygen, Metabolism, and Regeneration: Lessons from Mice.

Authors:  Ellen Heber-Katz
Journal:  Trends Mol Med       Date:  2017-10-05       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.